Clinical Trial Update: A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation II [Phase 1]

View source ↗

Summary

A Phase 1 study of an oral protein-based tablet (Oral Formulation II) in healthy male volunteers with high cholesterol has completed, sponsored by Novo Nordisk …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• Oral Formulation II Protein-based Tablet

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Healthy Volunteers; High Cholesterol | Phase 1 | Status: COMPLETED